Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Brazil Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20091
20102
20132
20152
20172
20181
20192
20202
20212
20221
20231
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting9
Completed8
Recruiting5
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Merck Sharp & Dohme LLC4
AbbVie2
Amgen2
Hoffmann-La Roche2
Telik2
CanariaBio Inc.1
Corcept Therapeutics1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms26
Fallopian Tube Neoplasms11
Carcinoma, Ovarian Epithelial5
Peritoneal Neoplasms5
Carcinoma, Non-Small-Cell Lung2
Breast Neoplasms1
Carcinoma, Renal Cell1
Carcinoma, Transitional Cell1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.